Can olanzapine cause hyponatremia (low serum sodium), and what is the recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Olanzapine and Hyponatremia

Yes, olanzapine can cause hyponatremia through SIADH (syndrome of inappropriate antidiuretic hormone secretion), and if hyponatremia develops, discontinue olanzapine immediately and manage based on severity and symptoms.

Mechanism and Risk

Olanzapine-induced hyponatremia occurs via SIADH, where the drug triggers non-osmotic ADH secretion leading to impaired free water clearance 1, 2, 3. This is a recognized but uncommon complication that can develop rapidly, even at low doses 4. Case reports document severe presentations including seizures, rhabdomyolysis, and coma requiring ICU admission 1, 2, 3.

The FDA label for olanzapine does not explicitly list hyponatremia as a warning, though it notes risks of orthostatic hypotension and metabolic disturbances 5. However, multiple case reports with rechallenge confirmation establish olanzapine as the causative agent 1, 6.

Diagnostic Approach

When hyponatremia is suspected in a patient on olanzapine, confirm SIADH by documenting:

  • Serum sodium <134 mEq/L with hypoosmolality (<275 mosm/kg)
  • Inappropriately high urine osmolality (>500 mosm/kg)
  • Urine sodium >20-40 mEq/L
  • Clinical euvolemia (no edema, ascites, or dehydration)
  • Exclusion of hypothyroidism, adrenal insufficiency, and other causes 7, 8

Critical distinction: Rule out psychogenic polydipsia, which is common in schizophrenia patients and presents differently than SIADH 3.

Management Algorithm

Symptomatic or Severe Hyponatremia (Na <120-125 mEq/L with symptoms)

Immediate actions:

  1. Discontinue olanzapine - This is the primary intervention 8, 1, 2
  2. Administer hypertonic 3% saline as 100-150 mL IV bolus for life-threatening symptoms (seizures, altered mental status, coma) 7, 9
  3. Target correction: 5 mmol/L in first hour for severe symptoms, then limit to 4-8 mEq/L per 24 hours, not exceeding 8-10 mEq/L per day to prevent osmotic demyelination syndrome 10, 11, 9, 12
  4. Monitor serum sodium every 2-4 hours initially 9

Moderate Hyponatremia (Na 120-125 mEq/L, asymptomatic)

  1. Stop olanzapine 8
  2. Fluid restriction to 1,000 mL/day 10
  3. Discontinue any implicated medications 8
  4. Consider albumin infusion in select cases 10
  5. Monitor electrolytes closely

Mild Hyponatremia (Na 126-135 mEq/L)

  1. Monitor serum sodium levels closely
  2. Consider stopping or reducing olanzapine dose
  3. Adequate oral salt intake
  4. No water restriction needed if asymptomatic 13, 10

Second-Line Therapies

If olanzapine cannot be discontinued or hyponatremia persists:

  • Oral urea - Effective and safe for SIADH 9
  • Vasopressin receptor antagonists (vaptans) - Use with extreme caution, short-term only (≤30 days), requires hospital monitoring due to overcorrection risk 14, 15, 10, 8
  • Demeclocycline or lithium - Alternative options 7

Critical Pitfalls

Avoid overcorrection: Correcting sodium >10-12 mEq/L per 24 hours significantly increases risk of osmotic demyelination syndrome (central pontine myelinolysis), which presents 2-7 days post-correction with dysarthria, dysphagia, quadriparesis, and can be irreversible 10, 11, 12. If overcorrection occurs, consider relowering with desmopressin or electrolyte-free water 10.

Do not use fluid restriction alone in severe symptomatic cases - it is ineffective and delays appropriate treatment 7.

Monitor for rapid onset: Hyponatremia can develop quickly after dose escalation 1, 4, requiring vigilance especially in the first weeks after starting or increasing olanzapine.

Rechallenge is contraindicated: Once olanzapine-induced hyponatremia is confirmed, switching to an alternative antipsychotic is mandatory 1, 6.

References

Research

Olanzapine induced hyponatremia and rhabdomyolysis.

Clinical case reports, 2023

Research

A case report of rapid-onset hyponatremia induced by low-dose olanzapine.

Journal of family medicine and primary care, 2017

Research

Hyponatremia with Olanzapine - A Suspected Association.

Shanghai archives of psychiatry, 2017

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

Treatment Guidelines for Hyponatremia: Stay the Course.

Clinical journal of the American Society of Nephrology : CJASN, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.